WallStreetZenWallStreetZen

NYSEMKT: SER
Serina Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

SER past revenue growth

How has SER's revenue growth performed historically?
Company
317.65%
Industry
144.63%
Market
17.55%
SER's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SER's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SER's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SER earnings and revenue history

Current Revenue
$142.0k
Current Earnings
-$14.8M
Current Profit Margin
-10,424.6%

SER Return on Equity

Insufficient data to display

Be the first to know when SER announces earnings.

SER Return on Assets

Current Company
-120.9%
Current Industry
2.9%
SER is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SER Return on Capital Employed

Current Company
-163.66%
Current Industry
19.5%
SER's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SER vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SER$142.00k-$9.77M-$14.80M-36.69%N/A
CNTX$0.00-$23.90M-$23.96MN/AN/A
LUMO$2.05M-$34.02M-$34.03M-30.31%N/A
LSTA$0.00-$22.98M-$20.84MN/AN/A
SYBX$3.37M-$51.97M-$57.28M+5.99%N/A
View Top Biotech Stocks

SER earnings dates

Next earnings date
May 13, 2024

Serina Therapeutics Earnings & Revenue FAQ

What were SER's earnings last quarter?

On Invalid Date, Serina Therapeutics (NYSEMKT: SER) reported Q4 2023 earnings per share (EPS) of -$3.17, up 18.87% year over year. Total Serina Therapeutics earnings for the quarter were -$3.46 million. In the same quarter last year, Serina Therapeutics's earnings per share (EPS) was -$2.67.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.

What was SER's earnings growth in the past year?

As of Q2 2024, Serina Therapeutics's earnings has grown year over year. Serina Therapeutics's earnings in the past year totalled -$14.80 million.

What is SER's earnings date?

Serina Therapeutics's earnings date is Invalid Date. Add SER to your watchlist to be reminded of SER's next earnings announcement.

What was SER's revenue last quarter?

On Invalid Date, Serina Therapeutics (NYSEMKT: SER) reported Q4 2023 revenue of $56.00 thousand up 600% year over year. In the same quarter last year, Serina Therapeutics's revenue was $8.00 thousand.

What was SER's revenue growth in the past year?

As of Q2 2024, Serina Therapeutics's revenue has grown 317.65% year over year. This is 173.02 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Serina Therapeutics's revenue in the past year totalled $142.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.